Showing results (1701-1710 of 5,501) with videos related to

Sort By:
Pageof 551
Inflammatory Bowel Diseases|November 9, 2016
Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel DiseaseAinsley M Robinson, Shakuntla V Gondalia, Avinash V Karpe, et al.
Inflammatory Bowel Diseases|November 9, 2016
Downregulation of MicroRNA-21 in Colonic CD3+ T Cells in UC RemissionYugo Ando, Luca Mazzurana, Marianne Forkel, et al.
Inflammatory Bowel Diseases|November 9, 2016
VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier DefectsMoorthy Krishnan, Harrison M Penrose, Nilay N Shah, et al.
Inflammatory Bowel Diseases|November 29, 2016
Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative ColitisDai Ishikawa, Takashi Sasaki, Taro Osada, et al.
Inflammatory Bowel Diseases|November 19, 2016
Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous DiseaseChengrui Huang, Suk See De Ravin, Adam R Paul, et al.
Inflammatory Bowel Diseases|May 3, 2014
Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's diseasePhillip Minar, Yael Haberman, Ingrid Jurickova, et al.
Inflammatory Bowel Diseases|May 3, 2014
Inviting patients with inflammatory bowel disease to active involvement in their own care: a randomized controlled trialAngelika Hueppe, Jana Langbrandtner, Heiner Raspe
Inflammatory Bowel Diseases|May 3, 2014
Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotypeDario Sorrentino, Claudio Avellini, Marco Geraci, et al.
Inflammatory Bowel Diseases|May 3, 2014
Antiproliferative effects of TRPV1 ligands on nonspecific and enteroantigen-specific T cells from wild-type and Trpv1 KO miceMohammed-Samir Belmaáti, Sanne Diemer, Tine Hvarness, et al.
Inflammatory Bowel Diseases|December 9, 2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist TherapyBruce E Sands, William J Sandborn, Gert Van Assche, et al.
Pageof 551